<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://feeds.transistor.fm/vat-trap" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>VAT Trap</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/vat-trap</itunes:new-feed-url>
    <description>The VAT Trap book, blog and digital media series reveals how visceral fat — the hidden metabolic organ — drives heart disease, hypertension, and diabetes. Drawing on 30 years of frontline cardiology and the latest in imaging, app-based tracking, and metabolic science, Dr Ed Leatham translates complex research into clear, actionable steps. Whether you want to avoid heart disease, stabilise your metabolism, or understand GLP-1 therapy, these four concise podcast seasons accompany a four book series that will help you see, track, and reverse the VAT trap. 

To join the mailing list click on the link below and add your email https://link.scvc.co.uk/vat-trap-join-newsletter</description>
    <copyright>Green Pages Publication </copyright>
    <podcast:guid>ef345762-debd-5ed8-adc5-c45e4c4ad857</podcast:guid>
    <podcast:locked owner="eleatham@medicalspace.uk">no</podcast:locked>
    <language>en</language>
    <pubDate>Tue, 03 Feb 2026 07:24:06 +0000</pubDate>
    <lastBuildDate>Wed, 25 Mar 2026 07:10:07 +0000</lastBuildDate>
    <link>http://vat-trap.com</link>
    <image>
      <url>https://img.transistorcdn.com/n81AYICpO4418Vp4346D-vK5g5vC624_IFUa_G-LB6Q/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MGUy/ZGRiNTM5NTcxNjgz/MGJkMTE4OTg0ZWRm/ZDg1NC5wbmc.jpg</url>
      <title>VAT Trap</title>
      <link>http://vat-trap.com</link>
    </image>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Fitness"/>
    </itunes:category>
    <itunes:type>episodic</itunes:type>
    <itunes:author>Dr Edward Leatham</itunes:author>
    <itunes:image href="https://img.transistorcdn.com/n81AYICpO4418Vp4346D-vK5g5vC624_IFUa_G-LB6Q/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MGUy/ZGRiNTM5NTcxNjgz/MGJkMTE4OTg0ZWRm/ZDg1NC5wbmc.jpg"/>
    <itunes:summary>The VAT Trap book, blog and digital media series reveals how visceral fat — the hidden metabolic organ — drives heart disease, hypertension, and diabetes. Drawing on 30 years of frontline cardiology and the latest in imaging, app-based tracking, and metabolic science, Dr Ed Leatham translates complex research into clear, actionable steps. Whether you want to avoid heart disease, stabilise your metabolism, or understand GLP-1 therapy, these four concise podcast seasons accompany a four book series that will help you see, track, and reverse the VAT trap. 

To join the mailing list click on the link below and add your email https://link.scvc.co.uk/vat-trap-join-newsletter</itunes:summary>
    <itunes:subtitle>The VAT Trap book, blog and digital media series reveals how visceral fat — the hidden metabolic organ — drives heart disease, hypertension, and diabetes.</itunes:subtitle>
    <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
    <itunes:owner>
      <itunes:name>Edward Leatham</itunes:name>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>Sarcopenia: Are We Diagnosing the Wrong Muscle Problem?</title>
      <itunes:episode>21</itunes:episode>
      <podcast:episode>21</podcast:episode>
      <itunes:title>Sarcopenia: Are We Diagnosing the Wrong Muscle Problem?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">132aa24e-73ef-46ca-bfc5-82390b7aa61b</guid>
      <link>https://share.transistor.fm/s/41b58f1e</link>
      <description>
        <![CDATA[<p>In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters.</p><p><a href="https://www.scvc.co.uk/vat/sarcopenia-wrong-muscle-problem/">Read Blog</a> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters.</p><p><a href="https://www.scvc.co.uk/vat/sarcopenia-wrong-muscle-problem/">Read Blog</a> </p>]]>
      </content:encoded>
      <pubDate>Wed, 25 Mar 2026 06:20:18 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/41b58f1e/75a6ee1f.mp3" length="19837566" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/7HunmTIDqDQ232FUxk4FwmPA2OKthtKrmKFOZ2XmwQg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wMTMz/M2MyMzQzYzU5YzMz/MzAwMjczYTY3MmNl/MTA2ZS5wbmc.jpg"/>
      <itunes:duration>1238</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters.</p><p><a href="https://www.scvc.co.uk/vat/sarcopenia-wrong-muscle-problem/">Read Blog</a> </p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>The Cardiometabolic Reset: Escaping the Metabolic Doom Loop</title>
      <itunes:episode>20</itunes:episode>
      <podcast:episode>20</podcast:episode>
      <itunes:title>The Cardiometabolic Reset: Escaping the Metabolic Doom Loop</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">34da7d67-1a1e-4e69-9499-9070b50f4559</guid>
      <link>https://share.transistor.fm/s/e7473d48</link>
      <description>
        <![CDATA[<p>The Eight-Month Metabolic Reset is a structured cardiometabolic programme designed to reduce visceral fat, preserve skeletal muscle strength, and improve glucose stability. Combining lifestyle change, targeted metabolic support, and clinical guidance, it helps break the cardiometabolic cycle and build sustainable long-term health beyond short-term weight loss.</p><p><a href="https://www.scvc.co.uk/vat/vat-metabolic-reset/">Read the blog</a><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>The Eight-Month Metabolic Reset is a structured cardiometabolic programme designed to reduce visceral fat, preserve skeletal muscle strength, and improve glucose stability. Combining lifestyle change, targeted metabolic support, and clinical guidance, it helps break the cardiometabolic cycle and build sustainable long-term health beyond short-term weight loss.</p><p><a href="https://www.scvc.co.uk/vat/vat-metabolic-reset/">Read the blog</a><br></p>]]>
      </content:encoded>
      <pubDate>Tue, 03 Mar 2026 10:13:53 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/e7473d48/0221db84.mp3" length="21948679" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/WrAzfLHay4sBSLtFcS1eeYa8offBikdoMn7bbnk4maQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84NmZi/MjgxMTRjNzE4NGY1/YWQxNWJjZTFmNzk0/YjU4Yi5qcGVn.jpg"/>
      <itunes:duration>1370</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>The Eight-Month Metabolic Reset is a structured cardiometabolic programme designed to reduce visceral fat, preserve skeletal muscle strength, and improve glucose stability. Combining lifestyle change, targeted metabolic support, and clinical guidance, it helps break the cardiometabolic cycle and build sustainable long-term health beyond short-term weight loss.</p><p><a href="https://www.scvc.co.uk/vat/vat-metabolic-reset/">Read the blog</a><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Prediabetes as a Therapeutic Target: A Cardiologist’s Editorial Perspective</title>
      <itunes:episode>19</itunes:episode>
      <podcast:episode>19</podcast:episode>
      <itunes:title>Prediabetes as a Therapeutic Target: A Cardiologist’s Editorial Perspective</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0b113d51-306b-40e5-9afe-beea5c103a5e</guid>
      <link>https://share.transistor.fm/s/290b2868</link>
      <description>
        <![CDATA[<p>Prediabetes should be viewed as an active cardiometabolic disease stage rather than a passive risk marker. Cardiovascular injury begins before overt diabetes, creating a critical window for intervention. Lifestyle therapy remains fundamental, while agents such as metformin, GLP-1 receptor agonists, dual incretin therapies, and SGLT2 inhibitors may help modify long-term cardiovascular risk.</p><p>https://www.scvc.co.uk/vat/glucose-insulin-dynamics/prediabetes-as-a-therapeutic-target-a-cardiologists-editorial-perspective/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Prediabetes should be viewed as an active cardiometabolic disease stage rather than a passive risk marker. Cardiovascular injury begins before overt diabetes, creating a critical window for intervention. Lifestyle therapy remains fundamental, while agents such as metformin, GLP-1 receptor agonists, dual incretin therapies, and SGLT2 inhibitors may help modify long-term cardiovascular risk.</p><p>https://www.scvc.co.uk/vat/glucose-insulin-dynamics/prediabetes-as-a-therapeutic-target-a-cardiologists-editorial-perspective/</p>]]>
      </content:encoded>
      <pubDate>Fri, 27 Feb 2026 08:54:14 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/290b2868/2d87c84c.mp3" length="20150197" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:duration>1256</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Prediabetes should be viewed as an active cardiometabolic disease stage rather than a passive risk marker. Cardiovascular injury begins before overt diabetes, creating a critical window for intervention. Lifestyle therapy remains fundamental, while agents such as metformin, GLP-1 receptor agonists, dual incretin therapies, and SGLT2 inhibitors may help modify long-term cardiovascular risk.</p><p>https://www.scvc.co.uk/vat/glucose-insulin-dynamics/prediabetes-as-a-therapeutic-target-a-cardiologists-editorial-perspective/</p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>PCSK9, visceral fat, and the modern metabolic environment</title>
      <itunes:episode>18</itunes:episode>
      <podcast:episode>18</podcast:episode>
      <itunes:title>PCSK9, visceral fat, and the modern metabolic environment</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7775ed38-be56-44a5-ba8e-12837897fb46</guid>
      <link>https://share.transistor.fm/s/ec819f7c</link>
      <description>
        <![CDATA[<p>Because cholesterol is a fat-like substance, it cannot dissolve or travel freely in blood, which is mostly water. To move around, it must be packaged into microscopic transport particles called lipoproteins. One of these, LDL (low-density lipoprotein), acts as the main delivery vehicle, carrying cholesterol from the liver to cells that need it for repair or hormone production. In small amounts, LDL cholesterol is therefore completely normal and necessary. The problem only begins when too much LDL remains circulating in the blood for too long.</p><p>For more details see the blog article https://www.scvc.co.uk/vat-trap/pcsk9-visceral-fat-and-the-modern-metabolic-environment/</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Because cholesterol is a fat-like substance, it cannot dissolve or travel freely in blood, which is mostly water. To move around, it must be packaged into microscopic transport particles called lipoproteins. One of these, LDL (low-density lipoprotein), acts as the main delivery vehicle, carrying cholesterol from the liver to cells that need it for repair or hormone production. In small amounts, LDL cholesterol is therefore completely normal and necessary. The problem only begins when too much LDL remains circulating in the blood for too long.</p><p>For more details see the blog article https://www.scvc.co.uk/vat-trap/pcsk9-visceral-fat-and-the-modern-metabolic-environment/</p>]]>
      </content:encoded>
      <pubDate>Sun, 22 Feb 2026 11:41:42 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/ec819f7c/f91f7cfa.mp3" length="21728956" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/lHjPlIMlxDg9L3WoNZQCejJJ3IYxKhlnQEu2ZnSAyQ4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hYWRk/ZGY3MDEwYzRkMzJk/N2RmOTc3N2E4MmI4/M2JmYi5wbmc.jpg"/>
      <itunes:duration>1357</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Because cholesterol is a fat-like substance, it cannot dissolve or travel freely in blood, which is mostly water. To move around, it must be packaged into microscopic transport particles called lipoproteins. One of these, LDL (low-density lipoprotein), acts as the main delivery vehicle, carrying cholesterol from the liver to cells that need it for repair or hormone production. In small amounts, LDL cholesterol is therefore completely normal and necessary. The problem only begins when too much LDL remains circulating in the blood for too long.</p><p>For more details see the blog article https://www.scvc.co.uk/vat-trap/pcsk9-visceral-fat-and-the-modern-metabolic-environment/</p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Why a Cardiologist Puts Cream on His Porridge</title>
      <itunes:episode>17</itunes:episode>
      <podcast:episode>17</podcast:episode>
      <itunes:title>Why a Cardiologist Puts Cream on His Porridge</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">720b29bf-2e7b-4e4e-b05c-96a349a2e2ea</guid>
      <link>https://share.transistor.fm/s/b065c17d</link>
      <description>
        <![CDATA[<p>Porridge is healthy — but adding cream may improve its metabolic impact. This cardiologist explains how moderating glucose spikes, protecting muscle and reducing small dense LDL formation can support cardiovascular health, particularly in patients with visceral adiposity and insulin resistance.</p><p>To read more see<br> <br><a href="https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/">https://www.scvc.co.uk/metabolic-health-weight/why-a-cardiologist-puts-cream-on-his-porridge/<br></a><br>To review all podcasts is series <a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Porridge is healthy — but adding cream may improve its metabolic impact. This cardiologist explains how moderating glucose spikes, protecting muscle and reducing small dense LDL formation can support cardiovascular health, particularly in patients with visceral adiposity and insulin resistance.</p><p>To read more see<br> <br><a href="https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/">https://www.scvc.co.uk/metabolic-health-weight/why-a-cardiologist-puts-cream-on-his-porridge/<br></a><br>To review all podcasts is series <a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a><br></p>]]>
      </content:encoded>
      <pubDate>Mon, 16 Feb 2026 15:53:32 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/b065c17d/bb285c09.mp3" length="16833293" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/IDbwI2-ceM-FcoJv7D2QGCmYsURe1pqmpsM4BIDPiHg/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MzEy/NTczZmRkMTBhMjcy/M2Y3ODhhYWQ3ZDg0/NDQxNy5wbmc.jpg"/>
      <itunes:duration>1048</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Porridge is healthy — but adding cream may improve its metabolic impact. This cardiologist explains how moderating glucose spikes, protecting muscle and reducing small dense LDL formation can support cardiovascular health, particularly in patients with visceral adiposity and insulin resistance.</p><p>To read more see<br> <br><a href="https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/">https://www.scvc.co.uk/metabolic-health-weight/why-a-cardiologist-puts-cream-on-his-porridge/<br></a><br>To review all podcasts is series <a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Menopause, Belly Fat and Long Term Health: why HRT and Visceral Fat Screening Matter</title>
      <itunes:episode>16</itunes:episode>
      <podcast:episode>16</podcast:episode>
      <itunes:title>Menopause, Belly Fat and Long Term Health: why HRT and Visceral Fat Screening Matter</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6c4a75ec-5a61-46c4-ba24-0e23468f1b6e</guid>
      <link>https://share.transistor.fm/s/ec10e9a0</link>
      <description>
        <![CDATA[<p>Menopause often brings a hidden shift in fat storage—from hips to abdomen—driven by falling oestrogen and loss of muscle. This article explains why visceral fat matters more than weight, how simple screening can detect risk early, and how HRT, lifestyle change, and modern tools can protect long-term heart and metabolic health.</p><p>To read more see<br> <br><a href="https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/">https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/<br></a><br>To review all podcasts is series <a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Menopause often brings a hidden shift in fat storage—from hips to abdomen—driven by falling oestrogen and loss of muscle. This article explains why visceral fat matters more than weight, how simple screening can detect risk early, and how HRT, lifestyle change, and modern tools can protect long-term heart and metabolic health.</p><p>To read more see<br> <br><a href="https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/">https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/<br></a><br>To review all podcasts is series <a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a></p>]]>
      </content:encoded>
      <pubDate>Wed, 04 Feb 2026 21:49:33 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/ec10e9a0/e4d22aa4.mp3" length="17093594" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/LTebvfWgom-QEuyBugfc0c15GEXoCj4FgpVoz9l9BhM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS85MWM1/ODVhYmY2N2E4OWQ1/ZDNkMjdkZDE1NDZl/OWQzNS5qcGVn.jpg"/>
      <itunes:duration>1065</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Menopause often brings a hidden shift in fat storage—from hips to abdomen—driven by falling oestrogen and loss of muscle. This article explains why visceral fat matters more than weight, how simple screening can detect risk early, and how HRT, lifestyle change, and modern tools can protect long-term heart and metabolic health.</p><p>To read more see<br> <br><a href="https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/">https://www.scvc.co.uk/vat/menopause-belly-fat-and-long-term-health-why-hrt-and-visceral-fat-screening-matter/<br></a><br>To review all podcasts is series <a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a></p>]]>
      </itunes:summary>
      <itunes:keywords>HRT, Visceral Adipose Tissue, Metabolic Health</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>If You Spend 2 Minutes Brushing Your Teeth, Why Not 10 Minutes Saving Your Life?</title>
      <itunes:episode>15</itunes:episode>
      <podcast:episode>15</podcast:episode>
      <itunes:title>If You Spend 2 Minutes Brushing Your Teeth, Why Not 10 Minutes Saving Your Life?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8e63fef6-8c4d-481a-9d82-f4fc1ad5ea60</guid>
      <link>https://share.transistor.fm/s/9005864b</link>
      <description>
        <![CDATA[<p>Ten minutes of strength training, five days a week, is enough to change metabolic health. Like brushing your teeth, it works because it’s sustainable. Keep the time fixed, increase the weights gradually, and focus on strength, not scales. Small daily habits protect muscle, reduce visceral fat, and support long-term health.</p><p>To read more see <a href="https://www.scvc.co.uk/metabolic-health/if-you-spend-2-minutes-brushing-your-teeth-why-not-10-minutes-saving-your-life/">https://www.scvc.co.uk/metabolic-health/if-you-spend-2-minutes-brushing-your-teeth-why-not-10-minutes-saving-your-life/</a></p><p><a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Ten minutes of strength training, five days a week, is enough to change metabolic health. Like brushing your teeth, it works because it’s sustainable. Keep the time fixed, increase the weights gradually, and focus on strength, not scales. Small daily habits protect muscle, reduce visceral fat, and support long-term health.</p><p>To read more see <a href="https://www.scvc.co.uk/metabolic-health/if-you-spend-2-minutes-brushing-your-teeth-why-not-10-minutes-saving-your-life/">https://www.scvc.co.uk/metabolic-health/if-you-spend-2-minutes-brushing-your-teeth-why-not-10-minutes-saving-your-life/</a></p><p><a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a></p>]]>
      </content:encoded>
      <pubDate>Tue, 03 Feb 2026 07:05:04 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/9005864b/81ccb27b.mp3" length="15645534" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/9Ht-uR4i6lL86Pw4IEBWi5iPPefX2B9A7y_FHXkoXU8/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82ZGU3/MWI0ZmExZWYwZDI1/ZTdkNzE5NGRhYTY1/MDc4Ny5qcGVn.jpg"/>
      <itunes:duration>975</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Ten minutes of strength training, five days a week, is enough to change metabolic health. Like brushing your teeth, it works because it’s sustainable. Keep the time fixed, increase the weights gradually, and focus on strength, not scales. Small daily habits protect muscle, reduce visceral fat, and support long-term health.</p><p>To read more see <a href="https://www.scvc.co.uk/metabolic-health/if-you-spend-2-minutes-brushing-your-teeth-why-not-10-minutes-saving-your-life/">https://www.scvc.co.uk/metabolic-health/if-you-spend-2-minutes-brushing-your-teeth-why-not-10-minutes-saving-your-life/</a></p><p><a href="https://feeds.transistor.fm/vat-trap">https://feeds.transistor.fm/vat-trap</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Sarcopenia: Are We Diagnosing the Correct Muscle Problem?</title>
      <itunes:episode>14</itunes:episode>
      <podcast:episode>14</podcast:episode>
      <itunes:title>Sarcopenia: Are We Diagnosing the Correct Muscle Problem?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">14c5a8b7-ad10-498a-97eb-c8eed9b69fac</guid>
      <link>https://share.transistor.fm/s/1036ec0f</link>
      <description>
        <![CDATA[<p>In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters. Read the <a href="https://www.scvc.co.uk/metabolic-health/sarcopenia-are-we-diagnosing-the-correct-muscle-problem/">blog here</a></p><p>For all podcasts see https://feeds.transistor.fm/vat-trap</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters. Read the <a href="https://www.scvc.co.uk/metabolic-health/sarcopenia-are-we-diagnosing-the-correct-muscle-problem/">blog here</a></p><p>For all podcasts see https://feeds.transistor.fm/vat-trap</p>]]>
      </content:encoded>
      <pubDate>Tue, 27 Jan 2026 14:14:49 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/1036ec0f/828b258c.mp3" length="16085657" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/b9T7deY6GlU6cpMLrcVTLlhW2LypPvAOuVGUaOgWjlU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81YmYw/OWNjOGRmMjk5NDI3/YjI1MzQ5NDc5NTI1/OGU2Zi5qcGVn.jpg"/>
      <itunes:duration>1003</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In cardiometabolic medicine, muscle is not a cosmetic tissue but a metabolic organ. Evidence consistently shows that strength, not muscle mass, predicts insulin resistance, cardiovascular risk, and survival. Many older adults are not losing muscle tissue — they are losing muscle function, and that is the pathology that matters. Read the <a href="https://www.scvc.co.uk/metabolic-health/sarcopenia-are-we-diagnosing-the-correct-muscle-problem/">blog here</a></p><p>For all podcasts see https://feeds.transistor.fm/vat-trap</p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Why GLP-1 Withdrawal Trials Fail — and Why Cardiometabolic Care Must Look Different</title>
      <itunes:episode>13</itunes:episode>
      <podcast:episode>13</podcast:episode>
      <itunes:title>Why GLP-1 Withdrawal Trials Fail — and Why Cardiometabolic Care Must Look Different</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">fdc59ed4-5d2d-48c4-aef5-5bfa5b3c9abd</guid>
      <link>https://share.transistor.fm/s/abd78914</link>
      <description>
        <![CDATA[<p>A 2026 BMJ systematic review confirms that weight regain is the rule after stopping pharmacological weight-management therapy. Across drug classes, most lost weight is regained within 24 months, with parallel loss of metabolic benefit. This reflects biological defence of adiposity, not patient failure.</p><p><a href="https://www.scvc.co.uk/metabolic-health/why-glp-1-withdrawal-trials-fail-and-why-cardiometabolic-care-must-look-different/">Blog</a> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>A 2026 BMJ systematic review confirms that weight regain is the rule after stopping pharmacological weight-management therapy. Across drug classes, most lost weight is regained within 24 months, with parallel loss of metabolic benefit. This reflects biological defence of adiposity, not patient failure.</p><p><a href="https://www.scvc.co.uk/metabolic-health/why-glp-1-withdrawal-trials-fail-and-why-cardiometabolic-care-must-look-different/">Blog</a> </p>]]>
      </content:encoded>
      <pubDate>Tue, 20 Jan 2026 07:18:38 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/abd78914/fd6a0f21.mp3" length="12792595" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/gfHYC29NFMTaMuMZ0DVZ-MUR51cmHPgeL7UYaIKLWvw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kYWU1/ZWRjZTUyMDI3NDhh/YTliMzljMzhiMTI4/OWY4YS5wbmc.jpg"/>
      <itunes:duration>798</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>A 2026 BMJ systematic review confirms that weight regain is the rule after stopping pharmacological weight-management therapy. Across drug classes, most lost weight is regained within 24 months, with parallel loss of metabolic benefit. This reflects biological defence of adiposity, not patient failure.</p><p><a href="https://www.scvc.co.uk/metabolic-health/why-glp-1-withdrawal-trials-fail-and-why-cardiometabolic-care-must-look-different/">Blog</a> </p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Smart body composition scales: helpful metabolic tool—or misleading distraction?</title>
      <itunes:episode>12</itunes:episode>
      <podcast:episode>12</podcast:episode>
      <itunes:title>Smart body composition scales: helpful metabolic tool—or misleading distraction?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">88f6eb96-af88-42b1-9da7-caa292f01aac</guid>
      <link>https://share.transistor.fm/s/b27f3cbc</link>
      <description>
        <![CDATA[<p>Smart body composition scales are not metabolic truth machines. Their value lies in engagement, not precision. During weight loss—especially with GLP-1 therapy—hydration and glycogen shifts distort “muscle” readings. Used within a tiered system that prioritises waist, strength, and function, they can support behaviour without undermining progress. </p><p>Blog see <a href="https://www.scvc.co.uk/metabolic-health/smart-body-composition-scales-helpful-metabolic-tool-or-misleading-distraction/">https://www.scvc.co.uk/metabolic-health/smart-body-composition-scales-helpful-metabolic-tool-or-misleading-distraction/</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Smart body composition scales are not metabolic truth machines. Their value lies in engagement, not precision. During weight loss—especially with GLP-1 therapy—hydration and glycogen shifts distort “muscle” readings. Used within a tiered system that prioritises waist, strength, and function, they can support behaviour without undermining progress. </p><p>Blog see <a href="https://www.scvc.co.uk/metabolic-health/smart-body-composition-scales-helpful-metabolic-tool-or-misleading-distraction/">https://www.scvc.co.uk/metabolic-health/smart-body-composition-scales-helpful-metabolic-tool-or-misleading-distraction/</a></p>]]>
      </content:encoded>
      <pubDate>Sat, 10 Jan 2026 16:53:12 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/b27f3cbc/9d9a77ac.mp3" length="13480833" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/b1r9WYes3fp309gxpFwxT5KdrjO24DyPaJ7N6NtdA6w/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82YWQy/OTAwYWZmY2I0YTg0/MDlmMTM2NmMxZmVl/ZTgwZS5qcGVn.jpg"/>
      <itunes:duration>840</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Smart body composition scales are not metabolic truth machines. Their value lies in engagement, not precision. During weight loss—especially with GLP-1 therapy—hydration and glycogen shifts distort “muscle” readings. Used within a tiered system that prioritises waist, strength, and function, they can support behaviour without undermining progress. </p><p>Blog see <a href="https://www.scvc.co.uk/metabolic-health/smart-body-composition-scales-helpful-metabolic-tool-or-misleading-distraction/">https://www.scvc.co.uk/metabolic-health/smart-body-composition-scales-helpful-metabolic-tool-or-misleading-distraction/</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>A New Year Reset: Why Your Waist Matters More Than Your Scales</title>
      <itunes:episode>11</itunes:episode>
      <podcast:episode>11</podcast:episode>
      <itunes:title>A New Year Reset: Why Your Waist Matters More Than Your Scales</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a3f9b756-2344-4258-928b-da828e1d1efc</guid>
      <link>https://share.transistor.fm/s/79bec8d7</link>
      <description>
        <![CDATA[<p>January isn’t just about weight loss. Much winter weight gain occurs as visceral fat, which drives insulin resistance and cardiovascular risk. Measuring your waist, not just your weight, gives a clearer picture of metabolic health. Building muscle and reducing visceral fat supports a healthier metabolism long after January ends.</p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>January isn’t just about weight loss. Much winter weight gain occurs as visceral fat, which drives insulin resistance and cardiovascular risk. Measuring your waist, not just your weight, gives a clearer picture of metabolic health. Building muscle and reducing visceral fat supports a healthier metabolism long after January ends.</p>]]>
      </content:encoded>
      <pubDate>Mon, 05 Jan 2026 16:55:43 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/79bec8d7/3add2dcb.mp3" length="16223807" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ePllDKHOEv49eBsj47PgzPWGgKpFNBweaf4bWKmO8gk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8wY2Qw/ZDg3MmRmZWJkM2Qy/MjE2ZDg5Mzc5M2Fk/NmI5Ny5qcGVn.jpg"/>
      <itunes:duration>1012</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>January isn’t just about weight loss. Much winter weight gain occurs as visceral fat, which drives insulin resistance and cardiovascular risk. Measuring your waist, not just your weight, gives a clearer picture of metabolic health. Building muscle and reducing visceral fat supports a healthier metabolism long after January ends.</p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk</title>
      <itunes:episode>10</itunes:episode>
      <podcast:episode>10</podcast:episode>
      <itunes:title>The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7d6b9f22-3a40-4feb-8051-816784300dba</guid>
      <link>https://share.transistor.fm/s/829399da</link>
      <description>
        <![CDATA[<p>GLP-1 drugs seem paradoxical: they enhance insulin action yet shrink dangerous belly fat. The explanation lies in restoring normal insulin timing, reducing chronic insulin exposure, and reversing fat “spillover” from liver to abdomen. Real patient cases show rapid visceral fat loss alongside smoother glucose profiles and lower cardiovascular risk.</p><p>See <a href="https://www.scvc.co.uk/metabolic-health/the-insulin-paradox-how-glp-1-drugs-reduce-belly-fat-and-heart-risk/">blog for more details</a></p><p>All <a href="https://feeds.transistor.fm/vat-trap">VAT TRAP Podcasts</a> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>GLP-1 drugs seem paradoxical: they enhance insulin action yet shrink dangerous belly fat. The explanation lies in restoring normal insulin timing, reducing chronic insulin exposure, and reversing fat “spillover” from liver to abdomen. Real patient cases show rapid visceral fat loss alongside smoother glucose profiles and lower cardiovascular risk.</p><p>See <a href="https://www.scvc.co.uk/metabolic-health/the-insulin-paradox-how-glp-1-drugs-reduce-belly-fat-and-heart-risk/">blog for more details</a></p><p>All <a href="https://feeds.transistor.fm/vat-trap">VAT TRAP Podcasts</a> </p>]]>
      </content:encoded>
      <pubDate>Sun, 14 Dec 2025 13:33:40 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/829399da/1f26b4f4.mp3" length="15002110" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:duration>935</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>GLP-1 drugs seem paradoxical: they enhance insulin action yet shrink dangerous belly fat. The explanation lies in restoring normal insulin timing, reducing chronic insulin exposure, and reversing fat “spillover” from liver to abdomen. Real patient cases show rapid visceral fat loss alongside smoother glucose profiles and lower cardiovascular risk.</p><p>See <a href="https://www.scvc.co.uk/metabolic-health/the-insulin-paradox-how-glp-1-drugs-reduce-belly-fat-and-heart-risk/">blog for more details</a></p><p>All <a href="https://feeds.transistor.fm/vat-trap">VAT TRAP Podcasts</a> </p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Why Protein Matters More Than Ever as We Age</title>
      <itunes:episode>9</itunes:episode>
      <podcast:episode>9</podcast:episode>
      <itunes:title>Why Protein Matters More Than Ever as We Age</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a856e82b-30bb-4411-b6d6-2be110672673</guid>
      <link>https://share.transistor.fm/s/d51a82ac</link>
      <description>
        <![CDATA[<p>Adequate protein and resistance training are essential for healthy ageing and reducing visceral fat. As we grow older, muscles become less responsive, making higher protein intake vital to preserve strength, metabolism, and independence. Building and feeding muscle is the most effective way to improve insulin sensitivity, raise metabolic rate, and burn harmful VAT.</p><p>For full story and links, see <a href="https://www.scvc.co.uk/metabolic-health/why-protein-matters-more-than-ever-as-we-age/">blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Adequate protein and resistance training are essential for healthy ageing and reducing visceral fat. As we grow older, muscles become less responsive, making higher protein intake vital to preserve strength, metabolism, and independence. Building and feeding muscle is the most effective way to improve insulin sensitivity, raise metabolic rate, and burn harmful VAT.</p><p>For full story and links, see <a href="https://www.scvc.co.uk/metabolic-health/why-protein-matters-more-than-ever-as-we-age/">blog</a></p>]]>
      </content:encoded>
      <pubDate>Mon, 08 Dec 2025 13:18:48 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/d51a82ac/c57d63b3.mp3" length="15187702" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/8B-qfKGjdhELPPPePIz5KFYW1goDWUCFveibFVFIPKs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83Yjk2/MWI5YzEzNzU0ZmVi/YTAxYTI0YzBkMTI0/Yzk4Mi5qcGVn.jpg"/>
      <itunes:duration>943</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Adequate protein and resistance training are essential for healthy ageing and reducing visceral fat. As we grow older, muscles become less responsive, making higher protein intake vital to preserve strength, metabolism, and independence. Building and feeding muscle is the most effective way to improve insulin sensitivity, raise metabolic rate, and burn harmful VAT.</p><p>For full story and links, see <a href="https://www.scvc.co.uk/metabolic-health/why-protein-matters-more-than-ever-as-we-age/">blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>“ChatGPT Says My Thyroid Might Be Underactive… What Next?”</title>
      <itunes:episode>8</itunes:episode>
      <podcast:episode>8</podcast:episode>
      <itunes:title>“ChatGPT Says My Thyroid Might Be Underactive… What Next?”</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">83277a12-8d3e-40c6-8d23-fdd5f14bcf28</guid>
      <link>https://share.transistor.fm/s/8db9fbc8</link>
      <description>
        <![CDATA[<p>Raised visceral fat quietly disrupts thyroid chemistry, increasing reverse T3 and lowering active T3 inside tissues. This pushes the body into metabolic “conservation mode” — slowing energy, mood and fat loss despite normal blood tests. Reducing VAT gradually restores healthy thyroid activation and metabolic resilience.</p><p>For the full story <a href="https://www.scvc.co.uk/metabolic-health/how-visceral-fat-disrupts-thyroid-function-and-why-modern-life-quietly-pushes-us-toward-low-thyroid-symptoms/">see blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Raised visceral fat quietly disrupts thyroid chemistry, increasing reverse T3 and lowering active T3 inside tissues. This pushes the body into metabolic “conservation mode” — slowing energy, mood and fat loss despite normal blood tests. Reducing VAT gradually restores healthy thyroid activation and metabolic resilience.</p><p>For the full story <a href="https://www.scvc.co.uk/metabolic-health/how-visceral-fat-disrupts-thyroid-function-and-why-modern-life-quietly-pushes-us-toward-low-thyroid-symptoms/">see blog</a></p>]]>
      </content:encoded>
      <pubDate>Fri, 28 Nov 2025 05:27:05 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/8db9fbc8/10d638c2.mp3" length="12195108" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/7HJByxR9cQl0L_9kA35Lkm8A81_iBxnIw2V2MDAP_dY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80ZjZh/MzhjYTk5Y2U3MjY0/ODQ4ZTkyMmZlM2Zk/Mjk1MS5qcGVn.jpg"/>
      <itunes:duration>760</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Raised visceral fat quietly disrupts thyroid chemistry, increasing reverse T3 and lowering active T3 inside tissues. This pushes the body into metabolic “conservation mode” — slowing energy, mood and fat loss despite normal blood tests. Reducing VAT gradually restores healthy thyroid activation and metabolic resilience.</p><p>For the full story <a href="https://www.scvc.co.uk/metabolic-health/how-visceral-fat-disrupts-thyroid-function-and-why-modern-life-quietly-pushes-us-toward-low-thyroid-symptoms/">see blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Statins: who do you trust?</title>
      <itunes:episode>3</itunes:episode>
      <podcast:episode>3</podcast:episode>
      <itunes:title>Statins: who do you trust?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e99cdbee-a39a-4d05-92b5-70ee5e3974dc</guid>
      <link>https://share.transistor.fm/s/719406d5</link>
      <description>
        <![CDATA[<p>One of the greatest challenges in the online world is investigator bias. Any “expert” with a strong conviction — whether pro- or anti-statin — can easily find studies that appear to confirm their view. The internet is full of such cherry-picked data. When presented with confident authority, this can sound utterly convincing to a lay audience. The reality is that true medical understanding does not come from one paper, one YouTube video, or one self-proclaimed authority.</p><p>Read the <a href="https://www.scvc.co.uk/metabolic-health/who-can-you-trust-the-rise-of-anti-statin-misinformation-online/">full blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>One of the greatest challenges in the online world is investigator bias. Any “expert” with a strong conviction — whether pro- or anti-statin — can easily find studies that appear to confirm their view. The internet is full of such cherry-picked data. When presented with confident authority, this can sound utterly convincing to a lay audience. The reality is that true medical understanding does not come from one paper, one YouTube video, or one self-proclaimed authority.</p><p>Read the <a href="https://www.scvc.co.uk/metabolic-health/who-can-you-trust-the-rise-of-anti-statin-misinformation-online/">full blog</a></p>]]>
      </content:encoded>
      <pubDate>Mon, 24 Nov 2025 09:00:00 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/719406d5/c2634fe7.mp3" length="13628264" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ybZF6sLwh5CgF2dK4wwOwUjcuCB6i5fTx0A9CJbIIhY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNWQz/MzEzOTVjZDMzNzFl/ODdkOWY3YzQ3MDk2/MGE2Yy5qcGc.jpg"/>
      <itunes:duration>848</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>One of the greatest challenges in the online world is investigator bias. Any “expert” with a strong conviction — whether pro- or anti-statin — can easily find studies that appear to confirm their view. The internet is full of such cherry-picked data. When presented with confident authority, this can sound utterly convincing to a lay audience. The reality is that true medical understanding does not come from one paper, one YouTube video, or one self-proclaimed authority.</p><p>Read the <a href="https://www.scvc.co.uk/metabolic-health/who-can-you-trust-the-rise-of-anti-statin-misinformation-online/">full blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>What Your Glucose Curve Is Trying to Tell You: Why Continuous Glucose Monitoring Matters Long Before Diabetes</title>
      <itunes:episode>7</itunes:episode>
      <podcast:episode>7</podcast:episode>
      <itunes:title>What Your Glucose Curve Is Trying to Tell You: Why Continuous Glucose Monitoring Matters Long Before Diabetes</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0fd39e3d-1cbf-4040-b726-badb7c1fe0b9</guid>
      <link>https://share.transistor.fm/s/54d2dd4a</link>
      <description>
        <![CDATA[<p>At Surrey Cardiovascular Clinic, we have seen a pattern: some people whose blood sugar (HbA₁c) is technically “normal” are quietly drifting towards diabetes. Their blood tests look fine — but their day-to-day glucose readings tell another story.</p><p><a href="https://www.scvc.co.uk/metabolic-health/what-your-glucose-curve-is-trying-to-tell-you-why-continuous-glucose-monitoring-matters-long-before-diabetes/">Full blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>At Surrey Cardiovascular Clinic, we have seen a pattern: some people whose blood sugar (HbA₁c) is technically “normal” are quietly drifting towards diabetes. Their blood tests look fine — but their day-to-day glucose readings tell another story.</p><p><a href="https://www.scvc.co.uk/metabolic-health/what-your-glucose-curve-is-trying-to-tell-you-why-continuous-glucose-monitoring-matters-long-before-diabetes/">Full blog</a></p>]]>
      </content:encoded>
      <pubDate>Mon, 17 Nov 2025 12:16:39 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/54d2dd4a/6224791b.mp3" length="13777079" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/BeO4xtFPIRfee6ZVn2uH6TLO3OqujcQ6f27Qr1VfQNs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81OGFi/MGRkZjI4N2ZiMDg4/NDZkM2FkNmI0NDkw/YzkwNC5wbmc.jpg"/>
      <itunes:duration>860</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>At Surrey Cardiovascular Clinic, we have seen a pattern: some people whose blood sugar (HbA₁c) is technically “normal” are quietly drifting towards diabetes. Their blood tests look fine — but their day-to-day glucose readings tell another story.</p><p><a href="https://www.scvc.co.uk/metabolic-health/what-your-glucose-curve-is-trying-to-tell-you-why-continuous-glucose-monitoring-matters-long-before-diabetes/">Full blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>What Keto and Atkins Diets Do</title>
      <itunes:episode>6</itunes:episode>
      <podcast:episode>6</podcast:episode>
      <itunes:title>What Keto and Atkins Diets Do</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7239d1f4-9bad-442a-903d-61833a69737f</guid>
      <link>https://share.transistor.fm/s/d4869796</link>
      <description>
        <![CDATA[<p>Multiple studies show that <strong>low-carb, high-fat diets</strong> tend to shift LDL particles toward larger, <strong>more buoyant LDL (pattern A)</strong>.<br>These particles are considered <strong>less atherogenic</strong> than small, dense LDL (pattern B), typical of insulin resistance.</p><p>Therefore, while <strong>LDL-C concentration may rise</strong>, <strong>LDL particle number (apoB)</strong> or <strong>non-HDL cholesterol</strong> may not rise proportionally — and inflammation markers (hs-CRP, TG/HDL ratio) often fall.</p><p><br><a href="https://www.scvc.co.uk/metabolic-health/overview-what-keto-and-atkins-diets-do/">Read full blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Multiple studies show that <strong>low-carb, high-fat diets</strong> tend to shift LDL particles toward larger, <strong>more buoyant LDL (pattern A)</strong>.<br>These particles are considered <strong>less atherogenic</strong> than small, dense LDL (pattern B), typical of insulin resistance.</p><p>Therefore, while <strong>LDL-C concentration may rise</strong>, <strong>LDL particle number (apoB)</strong> or <strong>non-HDL cholesterol</strong> may not rise proportionally — and inflammation markers (hs-CRP, TG/HDL ratio) often fall.</p><p><br><a href="https://www.scvc.co.uk/metabolic-health/overview-what-keto-and-atkins-diets-do/">Read full blog</a></p>]]>
      </content:encoded>
      <pubDate>Mon, 10 Nov 2025 16:53:05 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/d4869796/56715077.mp3" length="11663267" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/jclnzhcZB300y771sZFD0Q_0N8tlqYye693zrRp9zwc/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xNDE4/NmJlODAzNGRiMTNi/OTY4ZGEyZDM2YjI1/MDg5ZC5wbmc.jpg"/>
      <itunes:duration>723</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Multiple studies show that <strong>low-carb, high-fat diets</strong> tend to shift LDL particles toward larger, <strong>more buoyant LDL (pattern A)</strong>.<br>These particles are considered <strong>less atherogenic</strong> than small, dense LDL (pattern B), typical of insulin resistance.</p><p>Therefore, while <strong>LDL-C concentration may rise</strong>, <strong>LDL particle number (apoB)</strong> or <strong>non-HDL cholesterol</strong> may not rise proportionally — and inflammation markers (hs-CRP, TG/HDL ratio) often fall.</p><p><br><a href="https://www.scvc.co.uk/metabolic-health/overview-what-keto-and-atkins-diets-do/">Read full blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>VAT</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>MASLD/MASH -metabolic dysfunction -associated steatotic liver disease: What You Need to Know</title>
      <itunes:episode>5</itunes:episode>
      <podcast:episode>5</podcast:episode>
      <itunes:title>MASLD/MASH -metabolic dysfunction -associated steatotic liver disease: What You Need to Know</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">27907c63-daf4-4788-b211-5b882c60ab97</guid>
      <link>https://share.transistor.fm/s/b36fd42f</link>
      <description>
        <![CDATA[<p>MASLD is a silent but important marker of metabolic health and another consequence of raised Visceral Adipose Tissue (VAT). Although often discovered by chance, it carries significant implications for both liver and cardiovascular wellbeing. Through caloric restriction, physical activity, improved nutrition, and early intervention, MASLD can usually be stabilised or reversed — protecting not just the liver, but the heart as well.</p><p>Read the <a href="https://www.scvc.co.uk/metabolic-health/masld-mash-metabolic-dysfunction-associated-steatotic-liver-disease-what-you-need-to-know/">full blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>MASLD is a silent but important marker of metabolic health and another consequence of raised Visceral Adipose Tissue (VAT). Although often discovered by chance, it carries significant implications for both liver and cardiovascular wellbeing. Through caloric restriction, physical activity, improved nutrition, and early intervention, MASLD can usually be stabilised or reversed — protecting not just the liver, but the heart as well.</p><p>Read the <a href="https://www.scvc.co.uk/metabolic-health/masld-mash-metabolic-dysfunction-associated-steatotic-liver-disease-what-you-need-to-know/">full blog</a></p>]]>
      </content:encoded>
      <pubDate>Mon, 03 Nov 2025 14:55:31 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/b36fd42f/e294714b.mp3" length="11624593" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/z-Em47xrqrZdtP8WSukrB9BWRUvzNJA2bPGbQrOqRNw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kNzNl/NDExNzI1YjAyMjc1/Nzg2OGZiZGJiMDdi/YTBmNy5wbmc.jpg"/>
      <itunes:duration>725</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>MASLD is a silent but important marker of metabolic health and another consequence of raised Visceral Adipose Tissue (VAT). Although often discovered by chance, it carries significant implications for both liver and cardiovascular wellbeing. Through caloric restriction, physical activity, improved nutrition, and early intervention, MASLD can usually be stabilised or reversed — protecting not just the liver, but the heart as well.</p><p>Read the <a href="https://www.scvc.co.uk/metabolic-health/masld-mash-metabolic-dysfunction-associated-steatotic-liver-disease-what-you-need-to-know/">full blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>The Hidden Culprit Behind Heart Disease: Small Dense LDL and the Fat You Can’t See</title>
      <itunes:episode>4</itunes:episode>
      <podcast:episode>4</podcast:episode>
      <itunes:title>The Hidden Culprit Behind Heart Disease: Small Dense LDL and the Fat You Can’t See</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">536e3367-560a-4193-a5f1-3af1d800fa11</guid>
      <link>https://share.transistor.fm/s/22e07889</link>
      <description>
        <![CDATA[<p>Small dense LDL (sdLDL) is the most harmful form of “bad cholesterol.” It forms when the liver overproduces VLDL — often driven by visceral fat and high insulin levels. Visceral fat sits deep around the organs and feeds directly into the liver, causing early metabolic disruption long before blood tests detect it.</p><p><a href="https://www.scvc.co.uk/metabolic-health/why-visceral-adipose-tissue-drives-bad-cholesterol-and-low-hdl/">For full blog</a> </p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>Small dense LDL (sdLDL) is the most harmful form of “bad cholesterol.” It forms when the liver overproduces VLDL — often driven by visceral fat and high insulin levels. Visceral fat sits deep around the organs and feeds directly into the liver, causing early metabolic disruption long before blood tests detect it.</p><p><a href="https://www.scvc.co.uk/metabolic-health/why-visceral-adipose-tissue-drives-bad-cholesterol-and-low-hdl/">For full blog</a> </p>]]>
      </content:encoded>
      <pubDate>Mon, 27 Oct 2025 06:26:35 +0000</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/22e07889/b7311db8.mp3" length="16522549" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/ySVpP8kK5m1vUT9ls2wlMBO8v7qCSv3T5BwPIo1nDXU/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84ZTYw/NDY4NzhiMTExYTM0/MGY3MzFjMzEyNWZi/OGYyNy5wbmc.jpg"/>
      <itunes:duration>1030</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>Small dense LDL (sdLDL) is the most harmful form of “bad cholesterol.” It forms when the liver overproduces VLDL — often driven by visceral fat and high insulin levels. Visceral fat sits deep around the organs and feeds directly into the liver, causing early metabolic disruption long before blood tests detect it.</p><p><a href="https://www.scvc.co.uk/metabolic-health/why-visceral-adipose-tissue-drives-bad-cholesterol-and-low-hdl/">For full blog</a> </p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>Cholesterol, LDL, and what we learnt from PCSK9 mutations in familial hypercholesterolaemia</title>
      <itunes:episode>2</itunes:episode>
      <podcast:episode>2</podcast:episode>
      <itunes:title>Cholesterol, LDL, and what we learnt from PCSK9 mutations in familial hypercholesterolaemia</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d5244774-1bed-4e96-9ced-39138de6bcbb</guid>
      <link>https://share.transistor.fm/s/6e01316f</link>
      <description>
        <![CDATA[<p>In families with inherited high cholesterol (familial hypercholesterolaemia), mutations in the <strong>PCSK9 gene</strong> have been identified which make this protein overactive. These are known as <strong>gain-of-function mutations</strong> — they increase PCSK9 activity and push LDL cholesterol to dangerous levels. For over 90% of people with raised LDL who do NOT have a mutation, there are alternative explanations outlined in a <a href="https://www.scvc.co.uk/metabolic-health/pcsk9-visceral-fat-and-the-modern-metabolic-environment/"><strong>related article</strong></a> and for  readers that are curious about this PCSK9 take a look at my <a href="https://docs.google.com/document/d/1kAIrJIqFMq0JDjpdSsr8BiJbksriE6wTxTSYwI3qlTE/edit?usp=sharing"><strong>technical article linked</strong></a> to the VAT Trap book series on LDL Cholesterol. <a href="https://www.scvc.co.uk/metabolic-health/cholesterol-ldl-and-what-we-learnt-from-pcsk9-mutations-in-familial-hypercholesterolaemia/">Read blog</a></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In families with inherited high cholesterol (familial hypercholesterolaemia), mutations in the <strong>PCSK9 gene</strong> have been identified which make this protein overactive. These are known as <strong>gain-of-function mutations</strong> — they increase PCSK9 activity and push LDL cholesterol to dangerous levels. For over 90% of people with raised LDL who do NOT have a mutation, there are alternative explanations outlined in a <a href="https://www.scvc.co.uk/metabolic-health/pcsk9-visceral-fat-and-the-modern-metabolic-environment/"><strong>related article</strong></a> and for  readers that are curious about this PCSK9 take a look at my <a href="https://docs.google.com/document/d/1kAIrJIqFMq0JDjpdSsr8BiJbksriE6wTxTSYwI3qlTE/edit?usp=sharing"><strong>technical article linked</strong></a> to the VAT Trap book series on LDL Cholesterol. <a href="https://www.scvc.co.uk/metabolic-health/cholesterol-ldl-and-what-we-learnt-from-pcsk9-mutations-in-familial-hypercholesterolaemia/">Read blog</a></p>]]>
      </content:encoded>
      <pubDate>Sat, 18 Oct 2025 07:48:46 +0100</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/6e01316f/a6bec023.mp3" length="17598645" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/3xFrc2OnGubhSC3bFYNSNrK19nhsKz48n5ndRuudaJQ/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS82ZDZl/ZDUzMWM3NmRlOGVi/NDA1Nzc5Y2RjMzMy/ZWZmMy5qcGVn.jpg"/>
      <itunes:duration>1098</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In families with inherited high cholesterol (familial hypercholesterolaemia), mutations in the <strong>PCSK9 gene</strong> have been identified which make this protein overactive. These are known as <strong>gain-of-function mutations</strong> — they increase PCSK9 activity and push LDL cholesterol to dangerous levels. For over 90% of people with raised LDL who do NOT have a mutation, there are alternative explanations outlined in a <a href="https://www.scvc.co.uk/metabolic-health/pcsk9-visceral-fat-and-the-modern-metabolic-environment/"><strong>related article</strong></a> and for  readers that are curious about this PCSK9 take a look at my <a href="https://docs.google.com/document/d/1kAIrJIqFMq0JDjpdSsr8BiJbksriE6wTxTSYwI3qlTE/edit?usp=sharing"><strong>technical article linked</strong></a> to the VAT Trap book series on LDL Cholesterol. <a href="https://www.scvc.co.uk/metabolic-health/cholesterol-ldl-and-what-we-learnt-from-pcsk9-mutations-in-familial-hypercholesterolaemia/">Read blog</a></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
      <podcast:transcript url="https://share.transistor.fm/s/6e01316f/transcription.vtt" type="text/vtt" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e01316f/transcription.srt" type="application/x-subrip" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e01316f/transcription.json" type="application/json" rel="captions"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e01316f/transcription.txt" type="text/plain"/>
      <podcast:transcript url="https://share.transistor.fm/s/6e01316f/transcription" type="text/html"/>
    </item>
    <item>
      <title>So what does determine your LDL (‘bad’) Cholesterol?</title>
      <itunes:episode>1</itunes:episode>
      <podcast:episode>1</podcast:episode>
      <itunes:title>So what does determine your LDL (‘bad’) Cholesterol?</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">45d85d4d-78c9-4237-9a37-5b8e77c0d057</guid>
      <link>https://share.transistor.fm/s/70d29967</link>
      <description>
        <![CDATA[<p>In the first podcast in the series, the discussion revolves around cholesterol and the fact that while your blood LDL cholesterol determines the development of coronary plaque, your levels are more about your genetics than necessarily what you eat. In contrast, what happens to coronary plaque over your lifetime and whether it causes a heart attack is more about 'inflammation',  what carbohydrates and UPF's you eat and your lifestyle. </p><p>Read <a href="https://www.scvc.co.uk/naked-heart/what-determines-ldl-bad-cholesterol/">full blog</a></p><p><br></p>]]>
      </description>
      <content:encoded>
        <![CDATA[<p>In the first podcast in the series, the discussion revolves around cholesterol and the fact that while your blood LDL cholesterol determines the development of coronary plaque, your levels are more about your genetics than necessarily what you eat. In contrast, what happens to coronary plaque over your lifetime and whether it causes a heart attack is more about 'inflammation',  what carbohydrates and UPF's you eat and your lifestyle. </p><p>Read <a href="https://www.scvc.co.uk/naked-heart/what-determines-ldl-bad-cholesterol/">full blog</a></p><p><br></p>]]>
      </content:encoded>
      <pubDate>Fri, 17 Oct 2025 08:23:35 +0100</pubDate>
      <author>Dr Edward Leatham</author>
      <enclosure url="https://media.transistor.fm/70d29967/774825ca.mp3" length="2249278" type="audio/mpeg"/>
      <itunes:author>Dr Edward Leatham</itunes:author>
      <itunes:image href="https://img.transistorcdn.com/Ts0iAMsTrsHBza4v07ZFcaaBBFPaB472ahuzc9d8OGM/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80NmNh/NjRjNjkwZDQ3Mzk5/YzY1NWE0ZTcwM2Vm/YzU1Ny5qcGc.jpg"/>
      <itunes:duration>555</itunes:duration>
      <itunes:summary>
        <![CDATA[<p>In the first podcast in the series, the discussion revolves around cholesterol and the fact that while your blood LDL cholesterol determines the development of coronary plaque, your levels are more about your genetics than necessarily what you eat. In contrast, what happens to coronary plaque over your lifetime and whether it causes a heart attack is more about 'inflammation',  what carbohydrates and UPF's you eat and your lifestyle. </p><p>Read <a href="https://www.scvc.co.uk/naked-heart/what-determines-ldl-bad-cholesterol/">full blog</a></p><p><br></p>]]>
      </itunes:summary>
      <itunes:keywords>Metabolic Health, VAT, Healthspan, Longevity, Prevention, LDL</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
